Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Multiple Myeloma 808Precursor Cell Lymphoblastic Leukemia-Lymphoma 171Recurrence 141Neoplasms, Plasma Cell 111Lymphoma 93Leukemia 91Neoplasms 81Burkitt Lymphoma 57Vomiting 51Lymphoma, Non-Hodgkin 50Immunoglobulin Light-chain Amyloidosis 50Lymphoma, Large B-Cell, Diffuse 44Nausea 38Lymphoma, Mantle-Cell 38Prostatic Neoplasms 31Lymphoma, Follicular 30Hodgkin Disease 29Waldenstrom Macroglobulinemia 27Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27Neoplasm Metastasis 26Leukemia, Lymphocytic, Chronic, B-Cell 26Carcinoma, Non-Small-Cell Lung 26Leukemia, Myeloid, Acute 25Breast Neoplasms 25Lung Neoplasms 23Amyloidosis 21Leukemia, Biphenotypic, Acute 18Lymphoma, B-Cell, Marginal Zone 17Lymphoma, Extranodal NK-T-Cell 16Smoldering Multiple Myeloma 15

Interventions

Surveys and Questionnaires 5Oxygen 2Dexamethasone 2Calcium Dobesilate 2Acupuncture Therapy 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Standard of Care 1Respiratory Therapy 1Rehabilitation 1Psychiatric Rehabilitation 1Midazolam 1Losartan 1Lisinopril 1Hypnosis 1Hematologic Tests 1Furosemide 1Fentanyl 1Exercise 1Educational Status 1Echocardiography 1Early Intervention, Educational 1Dexmedetomidine 1Caregivers 1Buspirone 1Behavior Therapy 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Dyspnea × Dexamethasone × Clear all
NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed
52 enrolled 13 charts
Other

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡